Login

Financial Snapshot

Revenue
TTM
$3.873B
Gross Margin
TTM
36.68%
Net Income
TTM
$386.7M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
166.34%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
$2.468B
Book Value
2026 Q1
$2.629B
Cash
2026 Q1
P/E
TTM
18.57
Free Cash Flow
TTM
$324.5M

Stock Price

Loading...
Market Cap: $7.1817 Billion

About Aptargroup Inc

AptarGroup Inc (NYSE: ATR) is a dispensing and drug delivery packaging company that designs and manufactures pumps, aerosol valves, closures, and elastomeric components used to dispense pharmaceutical, beauty, personal care, food, and beverage products. Revenue is transactional, generated by selling dispensing systems and packaging components to pharmaceutical manufacturers, consumer goods companies, and other branded product makers. The company operates three segments: Pharma, Beauty, and Closures. Pharma is the largest segment, representing approximately 46% of net sales and 69% of Adjusted EBITDA excluding non-allocated corporate costs in FY2025. The company operates 57 manufacturing facilities across North America, Europe, Latin America, China, and other Asia/Middle East regions as of the FY2025 10-K filed February 6, 2026. Pharma segment clean-room manufacturing facilities operate in Argentina, China, France, Germany, India, Switzerland, and the United States.

Revenue model
Transactional product sales of dispensing pumps, aerosol valves, closures, and elastomeric packaging components. Customers purchase components per unit of production. In certain cases, customers share in research and development expenses for customer-initiated projects. The company also provides drug development acceleration services within the Pharma segment.
Products and services
Primary products include dispensing pumps (finger-actuated systems for sprays, liquids, and lotions), aerosol valves (continuous spray and metered dose), dispensing and non-dispensing closures, elastomeric primary packaging components for injectable drugs, nasal drug delivery spray pumps, metered dose inhaler valves, active material science solutions, and digital health solutions. Beauty segment personal care products accounted for approximately 37% of that segment's net sales in FY2025. Closures segment reported net sales of $730.3 million in FY2025.
Customers and end markets
Pharmaceutical and healthcare companies (nasal drug delivery, MDI valves, injectable packaging), beauty and personal care brands (lotion pumps, spray pumps, aerosol valves for hair care, skin care, deodorants), home care (disinfectants, air fresheners, insecticides), food (salad dressing, spreads, food protection), and beverage (functional drinks, dairy). The company serves 10 end markets across a global customer base. No single customer concentration figure is disclosed in the excerpts.
Value-chain role
Upstream packaging component manufacturer and drug delivery device supplier sitting between raw material suppliers and finished-goods consumer or pharmaceutical brands. Aptar partners with pharmaceutical companies at the molecular development stage of a medication through regulatory approval and eventual market distribution.
Geographic exposure
57 manufacturing facilities globally as of FY2025: France (11), China (10), Latin America (9), North America (9), Rest of Europe/United Kingdom (8), Germany (6), Other Asia/Middle East (4). France and Germany together host 17 facilities. The Closures segment noted currency rates positively impacted net sales by 1% in FY2025, indicating material non-U.S. revenue exposure.

Source: SEC 10-K, filed 2026-02-06

Industry: Plastics Products, NEC Peers: Ball Corp BERRY GLOBAL GROUP, INC. Crown Holdings Inc Greif Inc Myers Industries Inc O-i Glass, Inc Silgan Holdings Inc TriMas Corp

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support